DolaraA: Deprescribing: A challenge for clinical cardiologists. Acta Cardiol, 2019; 13:1–3.
7.
KutnerJS, BlatchfordPJ, TaylorDHJr, et al.: Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomised clinical trial. JAMA Int Med, 2015; 175:691–700.
8.
McCulloughD: My Mother, Your Mother: Embracing ‘Slow Medicine’ the Compassionate Approach to Caring for Your Aging Loved Ones. NY: Harper Perennial, 2008.
9.
Le CouteurD, GnjidicD, McLachlanA: Deprescribing. Aust Prescr, 2011; 34:182–185.
10.
HuiD, Frisbee-HumeS, WilsonA, et al.: Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: A randomized clinical trial. JAMA, 2017; 318:1047–1056.
11.
SteinhauserKE, ChristakisNA, ClippEC, et al.: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA, 2000; 284:2476–2482.
12.
HosieA, PhillipsJL, LamLT, et al.: A multicomponent non-pharmacological intervention to prevent delirium for hospitalized people with advanced cancer: A phase II cluster randomized waitlist controlled trial (the PRESERVE pilot study). J Palliat Med, 2020 [Online ahead of print]; DOI: 10.1089/jpm.2019.0632.